Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that the MRC Brain Network Dynamics Unit has received Collaborative Award funding from Wellcome for a substantial multi-year research programme designed to advance the understanding of why dopamine-producing nerve cells are especially vulnerable in Parkinson’s.

The new Collaborative Award builds on the MRC BNDU’s interactions with colleagues at the Oxford Parkinson’s Disease Centre, and will bring three Oxford teams together with researchers based at the University of Ulm, Germany, and at University College London. As part of this collaboration, the MRC BNDU will leverage its leading expertise in high-resolution in vivo phenotyping of rodent models of Parkinson’s.

Wellcome Collaborative Awards promote the development of new ideas and speed the pace of discovery. The Awards fund teams of researchers, consisting of independent research groups, to work together on the most important scientific problems that can only be solved through collaborative efforts.

Professor Peter Magill, who will lead the MRC BNDU’s contribution to the collaboration, commented, 'This Collaborative Award presents an exciting opportunity for Unit researchers to team up with other experts and tackle the science from different angles using complementary approaches. It is an excellent fit with the Unit’s and Department’s wider strategies supporting both fundamental and translational neuroscience research.'

Similar stories

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Royal Academy of Engineering Research Fellowship

Dr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.

Three New Professors

Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.